John C. Thomas
CIK: 0001424620
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Dogwood Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 16, 2026DWTX
Dogwood Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
16.8K shares- - Jun 27, 2025DWTX
Dogwood Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
2.4K shares- - Jun 18, 2025DWTX
Dogwood Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
210 shares- - Jun 18, 2025DWTX
Dogwood Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
210 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 | DWTX Dogwood Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 16,800 | - | - | Direct |
| Jun 27, 2025 | DWTX Dogwood Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 2,362 | - | - | Direct |
| Jun 18, 2025 | DWTX Dogwood Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 210 | - | - | Direct |
| Jun 18, 2025 | DWTX Dogwood Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 210 | - | - | Direct |
1-4 of 4 transactions
About Thomas John C
Thomas John C (SEC CIK 0001424620) files insider reports with the SEC as Director of Dogwood Therapeutics, Inc. (DWTX).
Signal8 holds 3 ownership filings by Thomas John C, all Form 4s, filed between Jun 23, 2025 and Jun 17, 2026. Those filings report 4 transactions, from Jun 18, 2025 to Jun 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Thomas John C's filings is in ALPHARETTA, GA.
Recent filings by Thomas John C
Other insiders filing for Dogwood Therapeutics, Inc. (DWTX)
- Sealbond Ltd, Director
- De La Rosa Abel, Director
- Whitley Richard James, Director
- Keefer David R, Director
- Grosswald Ralph, SVP OF OPERATIONS
- Walsh Angela, Chief Financial Officer